Long-term use of dulaglutide may cause non-arteritic anterior ischemic optic neuropathy (NAION). Since it is commonly prescribed to diabetic patients, the irregularity in blood sugar levels may be a contributing factor in the risk of optic nerve damage.
NAION is diagnosed through a series of eye exams to confirm swelling of the optic nerve. Roughly 6,000 new NAION cases are recorded every year in the United States. According to an optometry study published in 2024, patients exposed to GLP-1 agonist drugs are 3.24 times more susceptible to developing NAION.
If you do not have a history of NAION but developed it only after using dulaglutide injections, you may be eligible to file a claim. The experts from Atraxia Law are well-versed in reviewing cases and will help you through the process.
We will review your medical records to establish a solid ground for filing your NAION claim. You must be diagnosed with NAION by a legitimate physician to be eligible. At Atraxia Law, we go the extra mile for our clients. We carefully review the case and ensure that you have a strong claim before we move forward to matching you with an attorney.